Assess the Risk: GIST


What's New
Bug fix...
Size:
1.9 MB
Category:
Medical
OS:
iOS
Price:
Free
Compatible:
iPad
Requirements:
Compatible with iPad.
Version:
1.0

Description - Assess the Risk: GIST

Novartis Pharmaceutical Corporation , the publisher behind many iOS app (ViaOpta Nav ,Sickle Cell Iron Invaders ,Sickle Cell Disease Resource Locator ,PatchMate ,MyNet Manager ,Dosing Calculator), brings Assess the Risk: GIST with a number of new features along with the usual bug fixes. Assess the Risk: GIST app has been update to version 1.0 with several major changes and improvements. App release that improves performance, provides several new options.

.


The Assess the Risk: GIST is now available as a free download on Apple Store for iPad owners. The application is designed for use in English language. It weighs in at only 1.9 MB to download. The new Assess the Risk: GIST app version 1.0 has been updated on 2014-11-19. The Apple Store includes a very useful feature that will check if your device and iOS version are both compatible with the app. Most iPhone and iPad are compatible. Here is the app`s compatibility information: Compatible with iPad. Requires iOS 6.0 or later.
More Info: Find more info about Assess the Risk: GIST in Novartis Pharmaceutical Corporation`s Official Website : http://www.novartisoncology.com/index.jsp


An interactive activity designed for use on an iPad, this program estimates the risk of recurrence in gastrointestinal stromal tumor (GIST) a GI cancer using various assessment methodologies. The application features 4 hypothetical GIST patients ...
Assess the Risk: GIST Medical Prognostic Factors Risk GistAssess the Risk: GIST Medical Prognostic Factors Risk GistAssess the Risk: GIST Medical Prognostic Factors Risk Gist


More in Medical -Assess the Risk: GIST

Factors Educational Prognostic Factors